Cambridge Antibody Technology Group plc acquired by AstraZeneca plc
|
|
|
|
|
based mainly on its ability to generate antibody therapeutics; primarily using phage display and the subsequently acquired ribosome display; technology | |
Korean Distributor : ¾Æ½ºÆ®¶óÁ¦³×Ä« ÄÚ¸®¾Æ (AstraZeneca Korea) |
Products information :
|
|
|
|
|
|
|
|
|
|